Due to this weakness, unlike other vascular diseases,[16, 17] simply providing extra VEGF‐C sources could not effectively promote the lymphangiogenesis in AVFs with hyperphosphatemia. This evidence concerns the gene VEGFC and hyperphosphatemia.